Results 161 to 170 of about 24,428 (246)

Skin Boosters: 2026 Updated

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Skin boosters are increasingly used to improve dermal quality through injectable and device‐assisted approaches; however, definitions and clinical evidence remain heterogeneous. Aims To provide an updated overview and propose a practical classification of skin boosters, including mechanisms, delivery methods, clinical outcomes, and limitations.
Kyu‐ho Yi, Hyunggyu Kang, Jong Keun Song, Olena Sydorchuk, Jeremy B. Green, Hugues Cartier, Roya Zarmehr Zamin, Benjamin Ascher   +7 more
wiley   +1 more source

International survey on the use of tranexamic acid in plastic surgery-Current practices and perspectives. [PDF]

JPRAS Open
Aranda IM, Fuchs B, Vollbach FH, Thierfelder N, Giunta RE, Koban K, Moellhoff N, Mert S.   +7 more
europepmc   +1 more source

Comparison of the Efficacy of Kligman's Formula Combined With 30% Topical Metformin Versus Kligman's Formula Alone in the Treatment of Melasma

Journal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Melasma is a common hyperpigmentation disorder primarily affecting women, influenced by ultraviolet exposure, hormones, and genetics. Kligman's formula is a first‐line therapy, but emerging evidence suggests that topical metformin, an antidiabetic with antimelanogenic effects, may enhance treatment outcomes.
Fariba Iraji, Fatemeh Mokhtari, Zeinab Kassab, Sarah Seyedyousefi, Jaleh Varshosaz   +4 more
wiley   +1 more source

Tranexamic Acid in Pediatric Care: A Comprehensive Overview. [PDF]

J Pediatr Pharmacol Ther
Alsabri M, Aziz MM, Fahmy K, Zayed A, Elkefl MT, Ebraheem EA, Nabawy MS.   +6 more
europepmc   +1 more source

Functional Aspects of Fibrin Structure Alterations by Tranexamic Acid in the Inhibition of Fibrinolysis. [PDF]

Biomolecules
Balog Virag K, Baráth B, Molnár K, Csikós P, Raska A, Szabó L, Nikolova N, Tenekedjiev K, Kolev K, Wohner N.   +9 more
europepmc   +1 more source

Does Combined Intravenous and Topical Tranexamic Acid Offer Additional Benefit Compared With Intravenous or Topical Alone in Open Elbow Arthrolysis—A Pilot Randomized Controlled Trial

Orthopaedic Surgery, Volume 18, Issue 6, Page 1183-1190, June 2026.
Open elbow arthrolysis is a common method for treating post‐traumatic elbow stiffness. Intravenous, topical, or combined tranexamic acid administration showed no significant difference in reducing postoperative blood loss after open elbow arthrolysis. However, both combined and topical tranexamic acid significantly reduced postoperative drainage volume
Chen Chen, Jianyu Zhang, Kehan Hua, Weitong Sun, Dan Xiao, Maoqi Gong, Yejun Zha, Xieyuan Jiang   +7 more
wiley   +1 more source

Role of Tranexamic Acid in Orthopedic Trauma: Current Evidence, Clinical Applications, and Ongoing Controversies. [PDF]

J Orthop Case Rep
Shah ZA, Parveen S, Sajjad A, Ashber I, Rathod R, Nawaz A.   +5 more
europepmc   +1 more source

The Efficacy of Tranexamic Acid in Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. [PDF]

Adv Orthop
Nagy B, Cho T, Hehl B, Suh J, Liu J.
europepmc   +1 more source

Efficacy of Tranexamic acid Microneedling versus Intradermal Injection of Tranexamic Acid in the Treatment of Melasma - A Randomised Controlled Trial.

Indian J Dermatol
Srijha M, Kaliyaperumal D, Dileep JE, Kuruvila S.   +3 more
europepmc   +1 more source

Histopathological evaluation of facial melasma treated with oral tranexamic acid alone and in combination with ketotifen. [PDF]

An Bras Dermatol
Cruz ACL, Cassiano DP, Miot HA, Espósito ACC, Hassum K, de Brito MB, E Silva Enokihara MMS, Lima Constantino MCC, Bottura HR, de Almeida JS, Bagatin E.   +10 more
europepmc   +1 more source